The Ultimate Showdown: Radial vs. Femoral Access in Acute Coronary Syndrome Patients Treated With Glycoprotein IIb/IIIa During Percutaneous Coronary Intervention

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine Pub Date : 2024-08-01 DOI:10.1016/j.carrev.2024.04.093

引用次数: 0

查看原文本刊更多论文

终极对决：经皮冠状动脉介入治疗过程中使用糖蛋白 IIb/IIIa 治疗急性冠状动脉综合征患者的桡动脉通路与股动脉通路的比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.30

自引率

5.90%

发文量

687

审稿时长

36 days

期刊介绍： Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.